North America Amniotic Products Market Forecast to 2028 – COVID

North America Amniotic Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes) and Amniotic Suspensions], Application (Wound Care, Orthopedics, Ophthalmology, and Other Applications), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Other End Users)

Report Code : BMIRE00026285 | Region : North America | Industry : Pharmaceuticals | Published Date : 23/Sep/2022

The North America amniotic products market is expected to grow from US$ 421.96 million in 2022 to US$ 689.98 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2022 to 2028.

According to a 2018 retrospective examination of Medicare users, 8.2 million persons suffered wounds that were infected or not The acute and chronic wound treatments are estimated to cost between US$ 28.1 billion and US$ 96.8 billion by Medicare. Surgical wounds were the most expensive, followed by diabetic foot ulcers, with outpatient wound care costs higher than inpatient wound care. Traumatic wounds are a significant clinical, social, and economic burden because of the rising healthcare expenditures, increasing aging population, identification of difficult-to-treat infection risks such as biofilms, and the global hazard of diabetes and obesity. Traumatic wounds are those that have not proceeded through the normal healing process and have been open for longer than a month. These wounds have a variety of causes, all of which place a strain on the healthcare system. Diabetic and obese patients are at a higher risk of getting chronic wounds. Most persons who have a long-term open wound also have additional serious health problems. Comorbidities complicate chronic wounds, making it difficult to follow chronic wounds as a disease in and of itself. In comparison to the overall burden of chronic wounds as a health care concern, research funding dedicated to study chronic wounds is disproportionately low. Wound healing using amniotic membrane grafts has some therapeutic potential. Early use of an amniotic membrane for ulcers, burns, and cutaneous injuries proved therapeutic. Therefore, an increasing number of traumatic wounds is boosting the amniotic product market.

By introducing new features and technologies, vendors in the North America amniotic products can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.

North America Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

North America Amniotic Products Market Segmentation

The North America amniotic products market is segmented on the basis of type, application, end user, and country. Based on type, the market is bifurcated into amniotic membranes and amniotic suspensions. The amniotic membranes segment dominated the market in 2022, and the market for this segment is expected to grow at the fastest pace during the forecast period. Based on application, the North America amniotic products market is segmented into wound care, orthopedics, ophthalmology, and other applications. The wound care segment dominated the market in 2022, whereas the market for the orthopedics segment is expected to grow at the fastest pace during the forecast period. Based on end user, the North America amniotic products market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment dominated the market in 2022. However, the market for the ambulatory surgical centers segment is expected to grow at the fastest pace during the forecast period. Based on country, the North America amniotic products market is segmented into the US, Canada, and Mexico.

Integra LifeSciences; Katena Products. Inc.; Lucina BioSciences; MiMedx; NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health, Inc.; Smith & Nephew; and Stryker are among the leading companies in the North America amniotic products market.

At 8.5% CAGR, the North America Amniotic Product Market is speculated to be worth US$ 646.44 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the North America amniotic product market was valued at US$ 421.96 million in 2022 and is expected to reach US$ 689.98 million by 2028, registering an annual growth rate of 8.5% from 2022 to 2028. Rising incidence of burn injuries and increasing number of traumatic wounds are the critical factors attributed to the market expansion.

Due to the high prevalence of burn wounds, demand for wound care biologics, such as amniotic membranes, has increased significantly. In 2019, a total of 8,378,122 new cases of burns were identified (95% UI, 10,363,109–6,531,887 cases). Burn fatality rates have been declining in many high-income nations, but child burn deaths are now approximately 7 times greater in low- and middle-income countries than in high-income countries. From 1990 to 2019, the burden of burns declined progressively and was thought to be reduced in most regions. Moreover, according to the Children's Burn Trust and the British Burn Association, 625 children are admitted to an NHS Burns Service each month due to burn or scald injuries. In 2017, the NHS's burns and scalds services treated more than 15,000 patients with these injuries, with a total cost of more than US$ 24.94 million (i.e., GBP 20 million). More than 40 of the total burn treatment admissions in 2017 were classified as extremely serious, with treatment procedures costing more than US$ 118,455.50 (GBP 95,000) per person. Biologic materials are now used in various surgical procedures thanks to recent tissue harvesting, screening, and banking advancements. Burns, nerve regeneration, soft tissue reconstructive surgeries, ophthalmic surgeries, and diabetic foot ulcer surgeries are just a few of the applications for amniotic membranes. Amniotic membrane has been demonstrated to improve healing rates, reduce infection rates, shorten hospital stays, and reduce the number of dressing changes required in burn patients. Therefore, it has a lot of scopes to improve outcomes and save money. The amniotic membrane is helpful in chronic wounds, such as diabetic foot ulcers, and it holds tremendous potential for the treatment of donor skin graft sites, wounds treated with skin grafts, and partial thickness burns. Thus, increasing burn cases are driving the amniotic product market.

On the contrary, complications and limitations associated with the use of amniotic membranes secret hurdles the growth of North America amniotic product market.

Based on type, the North America amniotic product market is segmented into amniotic membranes and amniotic suspensions. The amniotic membranes segment held 84.9% market share in 2022, amassing US$ 358.43 million. It is projected to garner US$ 603.01 million by 2028 to expand at 9.1% CAGR during 2022–2028.

Based on application, the North America amniotic product market is segmented into wound care, orthopedics, ophthalmology, and other applications. The periodontics segment held 39.1% market share in 2022, amassing US$ 164.99 million. It is projected to garner US$ 265.33 million by 2028 to expand at 8.2% CAGR during 2022–2028.

Based on end user, the North America amniotic product market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held 49.3% market share in 2022, amassing US$ 208.02 million. It is projected to garner US$ 343.31 million by 2028 to expand at 8.7% CAGR during 2022–2028.

Based on country, the North America amniotic product market is segmented into the US, Canada, and Mexico. Our regional analysis states that the US captured 79.8% market share in 2022. It was assessed at US$ 336.64 million in 2022 and is likely to hit US$ 554.70 million by 2028, exhibiting a CAGR of 5.7% during the forecast period.

Key players dominating the North America amniotic product market are Integra LifeSciences; Katena Products. Inc.; Lucina BioSciences; MiMedx; NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health, Inc.; Smith & Nephew; and Stryker among others.

In Feb 2021, Stryker completed the acquisition of Wright Medical, Inc. a global medical device company focused on extremities and biologics. This acquisition strengthens global market position in trauma and extremities, providing significant opportunities to drive innovation and reach more patients. In Jan 2020, Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. (ACell) for a $300 million cash upfront payment at closing subject to customary purchase price adjustments and cash payments of up to an additional $100 million upon achievement of certain revenue growth milestones. ACell is an innovative regenerative medicine company with a product portfolio based on MatriStem UBM, a proprietary porcine bladder matrix platform technology. The transaction is expected to close in the first quarter of 2021, subject to the satisfaction of customary conditions, including regulatory approvals. The acquisition of ACell is the next step in expanding Integras' Orthopedics and Tissue Technologies (OTT) segment. Following the completion of the previously announced sale of Integras' orthopedic business, which is expected to occur in early January, OTT will be referred to as the Tissue Technologies segment. Contact Us

Contact Person: Sameer Joshi

Phone: +1- 646- 491- 9876

Email id: [email protected]

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Amniotic Products Market – By Type

1.3.2 North America Amniotic Products Market – By Application

1.3.3 North America Amniotic Products Market – By End User

1.3.4 North America Amniotic Products Market – By Country

2. North America Amniotic Products Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Amniotic Products Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Amniotic Products Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidence of Burn Injuries

5.1.2 Increasing Number of Traumatic Wounds

5.2 Market Restraints

5.2.1 Complications and Limitations Associated with Use of Amniotic Membranes

5.3 Market Opportunities

5.3.1 Implementation of the 21st Century Cures Act (US)

5.4 Future Trends

5.4.1 Increasing Demand for Stem Cell Research and Regenerative Medicine

5.5 Impact Analysis

6. Amniotic Products Market– North America Analysis

6.1 North America Amniotic Products Market Revenue Forecast and Analysis

7. North America Amniotic Products Market Revenue and Forecast to 2028 – by Type

7.1 Overview

7.2 North America Amniotic Products Market, by Type, 2022 & 2028 (%)

7.3 Amniotic Membranes

7.3.1 Overview

7.3.2 Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Cryopreserved Amniotic Membranes

7.3.2.1.1 Cryopreserved Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Dehydrated Amniotic Membranes

7.3.2.2.1 Dehydrated Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.4 Amniotic Suspensions

7.4.1 Overview

7.4.2 Amniotic Suspensions: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8. North America Amniotic Products Market Revenue and Forecast to 2028 – by Application

8.1 Overview

8.2 Amniotic Products Market Share by Application - 2022 & 2028 (%)

8.3 Wound Care

8.3.1 Overview

8.3.2 Wound Care: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.4 Orthopedics

8.4.1 Overview

8.4.2 Orthopedics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.5 Ophthalmology

8.5.1 Overview

8.5.2 Ophthalmology: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.6 Other Applications

8.6.1 Overview

8.6.2 Other Applications: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9. North America Amniotic Products Market Revenue and Forecast to 2028 – by End User

9.1 Overview

9.2 North America Amniotic Products Market Share by End User - 2022 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 Ambulatory Surgical Centers: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9.5 Other End Users

9.5.1 Overview

9.5.2 Other End Users: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

10. North America Amniotic Products Market Revenue and Forecast to 2028 – by Country

10.1 Overview

10.1.1 North America: Amniotic Products Market, by Country, 2022 & 2028 (%)

10.1.1.1 US: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 US: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2 US Amniotic Products Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2.1 US Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 US Amniotic Products Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4 US Amniotic Products Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2 Canada: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 Canada: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2 Canada Amniotic Products Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2.1 Canada Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 Canada Amniotic Products Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4 Canada Amniotic Products Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3 Mexico: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Mexico: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2 Mexico Amniotic Products Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2.1 Mexico Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 Mexico Amniotic Products Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4 Mexico Amniotic Products Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. North America Amniotic Products Market–Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 MiMedx

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Smith & Nephew

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Integra LifeSciences

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Stryker

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Katena Products. Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 NuVision Biotherapies Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Lucina BioSciences

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Organogenesis, Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Sanuwave and Sanuwave Health, Inc.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1.             North America Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Amniotic Products Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Amniotic Products Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             US Amniotic Products Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada Amniotic Products Market, by Type-Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Canada Amniotic Products Market, by Application -Revenue and Forecast to 2028 (USD Million)

Table 9.             Canada Amniotic Products Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico Amniotic Products Market, by Type -Revenue and Forecast to 2028 (USD Million)

Table 11.          Mexico Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico Amniotic Products Market, by Application -Revenue and Forecast to 2028 (USD Million)

Table 13.          Mexico Amniotic Products Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms, North America Amniotic Products Market

LIST OF FIGURES.

Figure 1.           North America Amniotic Products Market Segmentation

Figure 2.           North America Amniotic Products Market – By Country

Figure 3.           North America Amniotic Products Market Overview

Figure 4.           North America Amniotic Membranes Held Largest Share by Type of Amniotic Products Market

Figure 5.           US to Show Significant Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Amniotic Products Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Amniotic Products Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        North America Amniotic Products Market, by Type, 2022 & 2028 (%)

Figure 11.        North America Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Cryopreserved Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Dehydrated Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Amniotic Suspensions: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Amniotic Products Market Share by Application - 2022 & 2028 (%)

Figure 16.        North America Wound Care: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        North America Orthopedics: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        North America Ophthalmology: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        North America Other Applications: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        North America Amniotic Products Market Share by End User - 2022 & 2028 (%)

Figure 21.        North America Hospitals and Clinics: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        North America Ambulatory Surgical Centers: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 23.        North America Other End Users: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        North America: Amniotic Products Market, by Key Country – Revenue (2022) (USD Million)

Figure 25.        North America: Amniotic Products Market, by Country, 2022 & 2028 (%)

Figure 26.        US: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Canada: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Mexico: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - North America Amniotic Products Market

● Integra LifeSciences

● Katena Products. Inc.

● Lucina BioSciences

● MiMedx

● NuVision Biotherapies Ltd

● Organogenesis, Inc.

● Sanuwave and Sanuwave Health, Inc.

● Smith & Nephew

● Stryker

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America amniotic products market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America amniotic products market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the amniotic products market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP